– Corpas M, Siddiqui MK, Soremekun O, Mathur R, Gill D, Fatumo S. Addressing Ancestry and Sex Bias in Pharmacogenomics. Annual Review of Pharmacology and Toxicology, 2024;64:53-64.
– Lauschke VM, Zhou Y, Ingelman-Sundberg M. Pharmacogenomics Beyond Single Common Genetic Variants: The Way Forward. Annual Review of Pharmacology and Toxicology, 2024;64:33-51.
– Rodríguez-Fernández K, Reynaldo-Fernández G, Reyes-González S, de Las Barreras C, Rodríguez-Vera L, Vlaar C, et al. New insights into the role of VKORC1 polymorphisms for optimal warfarin dose selection in Caribbean Hispanic patients through an external validation of a population PK/PD model. Biomed Pharmacother. 2024 Jan:170:115977.
– Hernandez M, Cullell N, Cendros M, Serra-Llovich A, Arranz MJ. Clinical Utility and Implementation of Pharmacogenomics for the Personalisation of Antipsychotic Treatments. Pharmaceutics. 2024;16(2):244.
Farmacogenómica: sesgos de ancestría y sexo, implementación, warfarina, antipsicóticos
Filed under Farmacogenómica by on . 
You must be logged in to post a comment. Login.
Leave a Comment